GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Short-Term Debt

Veritas In Silico (TSE:130A) Short-Term Debt : 円0.0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Short-Term Debt?

Veritas In Silico's Short-Term Debt for the quarter that ended in Dec. 2024 was 円0.0 Mil.

Veritas In Silico Short-Term Debt Historical Data

The historical data trend for Veritas In Silico's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Short-Term Debt Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Short-Term Debt
- - - -

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24
Short-Term Debt Get a 7-Day Free Trial - - - - -

Veritas In Silico Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Veritas In Silico Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Short-Term Debt
Comparable Companies
TSE:4598 TSE:4576 TSE:4570 TSE:4591 TSE:4572 TSE:4584 TSE:4891 TSE:4594 TSE:4884 TSE:4881 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Website
https://www.veritasinsilico.com
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines